Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...

"If you can unlock triple digit titers this is the real game that's needed to achieve competitive pricing and profitability" ...

AUSTIN, Texas and TOKYO, Nov. 14, 2025 /PRNewswire/ -- According to DataM Intelligence, the Cardiovascular Biologics Market Size was valued at approximately USD 2.20 billion in 2024 and is projected ...

Dyadic International Inc. (($DYAI)) has held its Q3 earnings call. Read on for the main highlights of the call. In a recent earnings call, Dyadic ...

Ready-to-use solution, developed in collaboration with GenScript, offers rapid and reliable quantification of His-tagged proteins -- Broadens Amperia's applications across recombinant protein research ...

The engineering and production of antibodies are vital in drug discovery, offering effective and precise therapeutics and diagnostic/prognostic materials for numerous diseases. Antibodies are proteins ...

Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.

For intramuscular vaccines, the standard hemagglutination inhibition (HAI) titer used to infer immune protection is at least ...

Congenital thrombotic thrombocytopenic purpura (TTP) results from severe hereditary deficiency of ADAMTS13. The efficacy and safety of recombinant ADAMTS13 and standard therapy (plasma-derived ...

Recombinant DNA (rDNA) has many uses in the society of today, from research and biotechnology to the medicine stocked on the shelves of pharmacies. The ability to manipulate the creation of DNA with ...